Response to ‘Validation of generalized drug‐related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes’

Abstract

Linked Article: Goldenberg et al. Br J Dermatol 2022; 186:583–585.

Response to: ‘Validation of generalized drug‐related rash diagnoses using International Classification of Diseases 9thand 10thRevision codes’: reply from the authors

“…Dear Editor, Guelimi et al evaluated the redundancy, methodological quality and discrepancies in 47 network meta-analyses (NMAs) on systemic treatments for psoriasis. 1 We had planned a similar study, but in light of this new study we have abandoned our project in order to reduce research waste.…”